CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the net proceeds to the company from its offering of 4,700,000 shares of common stock will be approximately $101 million. The offering is underwritten by Banc of America Securities LLC. The company expects the closing of the offering to occur on December 15, 2006.
